These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 28455195)

  • 1. A nationwide study of the extent and factors associated with fentanyl use in Australia.
    Gisev N; Larance B; Cama E; Nielsen S; Roxburgh A; Bruno R; Degenhardt L
    Res Social Adm Pharm; 2018 Mar; 14(3):303-308. PubMed ID: 28455195
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An ecological study of the extent and factors associated with the use of prescription and over-the-counter codeine in Australia.
    Gisev N; Nielsen S; Cama E; Larance B; Bruno R; Degenhardt L
    Eur J Clin Pharmacol; 2016 Apr; 72(4):469-94. PubMed ID: 26690771
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The extent and correlates of community-based pharmaceutical opioid utilisation in Australia.
    Degenhardt L; Gisev N; Cama E; Nielsen S; Larance B; Bruno R
    Pharmacoepidemiol Drug Saf; 2016 May; 25(5):521-38. PubMed ID: 26781123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. To what extent do data from pharmaceutical claims under-estimate opioid analgesic utilisation in Australia?
    Gisev N; Pearson SA; Karanges EA; Larance B; Buckley NA; Larney S; Dobbins T; Blanch B; Degenhardt L
    Pharmacoepidemiol Drug Saf; 2018 May; 27(5):550-555. PubMed ID: 29047196
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A population-based study of transdermal fentanyl initiation in Australian clinical practice.
    Gisev N; Pearson SA; Larance B; Larney S; Blanch B; Degenhardt L
    Eur J Clin Pharmacol; 2019 Mar; 75(3):401-408. PubMed ID: 30392109
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Utilisation of general practitioner services by socio-economic disadvantage and geographic remoteness.
    Turrell G; Oldenburg BF; Harris E; Jolley D
    Aust N Z J Public Health; 2004 Apr; 28(2):152-8. PubMed ID: 15233355
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trends in transdermal fentanyl utilisation and fatal fentanyl overdose across Australia (2003-2015).
    Rahman S; Trussell A; Pearson SA; Buckley NA; Karanges EA; Cairns R; Litchfield M; Todd A; Gisev N
    Drug Alcohol Rev; 2022 Feb; 41(2):435-443. PubMed ID: 34628699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. National utilization of transdermal fentanyl among community-dwelling older people in Finland.
    Bell JS; Klaukka T; Ahonen J; Hartikainen S
    Am J Geriatr Pharmacother; 2009 Dec; 7(6):355-61. PubMed ID: 20129256
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilisation of transdermal fentanyl in Germany from 2004 to 2006.
    Garbe E; Jobski K; Schmid U
    Pharmacoepidemiol Drug Saf; 2012 Feb; 21(2):191-8. PubMed ID: 21681850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilisation pattern of fentanyl transdermal system in The Netherlands.
    Breekveldt-Postma NS; Penning-van Beest FJ; Herings RM
    Pharmacoepidemiol Drug Saf; 2005 Feb; 14(2):129-34. PubMed ID: 15386723
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Trends in opioid analgesics sales to community pharmacies and hospitals in Italy (2000-2010).
    Caraceni AT; Brunelli C; Rocco P; Minghetti P
    Minerva Anestesiol; 2013 Aug; 79(8):906-14. PubMed ID: 23558762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Opioid analgesic prescribing in Australia: a focus on gender and age.
    Hollingworth SA; Gray PD; Hall WD; Najman JM
    Pharmacoepidemiol Drug Saf; 2015 Jun; 24(6):628-36. PubMed ID: 25845470
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utilization of transdermal fentanyl in German nursing home residents from 2010 to 2014.
    Jobski K; Bantel C; Hoffmann F
    Pharmacoepidemiol Drug Saf; 2019 May; 28(5):754-759. PubMed ID: 30861622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inappropriate use of high doses of transdermal fentanyl at admission to a palliative care unit.
    Botterman J; Criel N
    Palliat Med; 2011 Mar; 25(2):111-6. PubMed ID: 20937611
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in mortality rates in Australia: correlation with Indigenous status, remoteness and socio-economic deprivation.
    Wilkinson D; Ryan P; Hiller J
    J Public Health Med; 2001 Mar; 23(1):74-7. PubMed ID: 11315700
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prevalence of pain and analgesia use in the Australian population: Findings from the 2011 to 2012 Australian National Health Survey.
    Miller A; Sanderson K; Bruno R; Breslin M; Neil AL
    Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1403-1410. PubMed ID: 28895247
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The privilege paradox: Geographic areas with highest socio-economic advantage have the lowest rates of vaccination.
    Bryden GM; Browne M; Rockloff M; Unsworth C
    Vaccine; 2019 Jul; 37(32):4525-4532. PubMed ID: 31262584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A feasibility study of transdermal buprenorphine versus transdermal fentanyl in the long-term management of persistent non-cancer pain.
    Mitra F; Chowdhury S; Shelley M; Williams G
    Pain Med; 2013 Jan; 14(1):75-83. PubMed ID: 23320402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of long-acting opioid use and oral versus transdermal route among older Medicaid beneficiaries.
    Rigler SK; Shireman TI; Kallenbach L
    Am J Geriatr Pharmacother; 2007 Jun; 5(2):91-9. PubMed ID: 17719511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilisation of transdermal fentanyl in Germany from 2004 to 2006.
    Garbe E; Jobski K
    Pharmacoepidemiol Drug Saf; 2012 Aug; 21(8):904-5. PubMed ID: 22736572
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.